AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 77, Issue 3 351-353, Copyright © 1987 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beverly, L N
Right arrow Articles by Soong, S J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beverly, L N
Right arrow Articles by Soong, S J
A comparison of estrogen and progesterone receptors in black and white breast cancer patients.

L N Beverly, W D Flanders, R C Go and S J Soong

After standardization for age and menopausal status, the prevalence of estrogen receptor positivity among 88 White breast cancer patients was about .72 compared with a prevalence of about .54 among Black patients. The prevalence of progesterone receptor positivity was also higher among White than among Black patients, although the magnitude of the difference was smaller. These differences were unchanged after adjustment for tumor size and nodal and distant metastases in addition to age and menopausal status.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
I. Poola, S. A.W. Fuqua, R. L. De Witty, J. Abraham, J. J. Marshallack, and A. Liu
Estrogen Receptor {alpha}-Negative Breast Cancer Tissues Express Significant Levels of Estrogen-Independent Transcription Factors, ER{beta}1 and ER{beta}5: Potential Molecular Targets for Chemoprevention
Clin. Cancer Res., October 15, 2005; 11(20): 7579 - 7585.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. A. Marchbanks, J. A. McDonald, H. G. Wilson, S. G. Folger, M. G. Mandel, J. R. Daling, L. Bernstein, K. E. Malone, G. Ursin, B. L. Strom, et al.
Oral Contraceptives and the Risk of Breast Cancer
N. Engl. J. Med., June 27, 2002; 346(26): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
B. A. Miller, B. F. Hankey, and T. L. Thomas
Impact of Sociodemographic Factors, Hormone Receptor Status, and Tumor Grade on Ethnic Differences in Tumor Stage and Size for Breast Cancer in US Women
Am. J. Epidemiol., March 15, 2002; 155(6): 534 - 545.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. J. Dignam
Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 36 - 43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Public Health Association